DOI:
10.1055/s-00000173
Neuroradiologie Scan
LinksClose Window
References
Fox RJ, Coffey CS, Cudkowicz ME. et al.
Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis.
Contemp Clin Trials 2016;
50: 166-177
We do not assume any responsibility for the contents of the web pages of other providers.